Kiora Pharmaceuticals, Inc.
Hedge Funds Holdings

Last updated:

Kiora Pharmaceuticals, Inc.‘s stocks are currently a part of 9 hedge funds’ portfolios, which represents 6.65% of the total amount of its stocks outstanding. This makes up a total of 48.66K shares of Kiora Pharmaceuticals, Inc.. Compared to the previous quarter, the number fell by -67.81% or -102.50K shares fewer. As for the holding position changes, 11.11% (1) of current hedge fund investors increased the number of shares held, 11.11% (1) of current holders sold a part of the shares held, and 11.11% (1) closed the holdings completely. 4 hedge funds are new holders of Kiora Pharmaceuticals, Inc. stock in Q1 2023, it is 44.44% of total holders.

Hedge funds holding Kiora Pharmaceuticals (Q4 2021 – Q1 2023)

Number of hedge funds
Q4 2021 10
Q1 2022 12
Q2 2022 10
Q3 2022 5
Q4 2022 10
Q1 2023 9

Hedge funds changes in Kiora Pharmaceuticals positions (Q4 2021 – Q1 2023)

Changes in positions
Q4 2021 100000
Q1 2022 52230
Q2 2022 3225-2
Q3 2022 50010-10
Q4 2022 7212-2
Q1 2023 41112

Top 50 hedge fund holders of Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX)

Hedge fund Value Shares owned Portfolio share
BLACKROCK INC. Larry Fink 89K 14.46K 0.000%
GEODE CAPITAL MANAGEMENT, LLC 86K 14.00K 0.000%
MORGAN STANLEY 15K 2.36K 0.000%
UBS GROUP AG 13K 2.13K 0.000%
SPARTAN FUND MANAGEMENT INC. 6K 1K 0.002%
CITADEL ADVISORS LLC Ken Griffin 0 0 0.000%
PRICE T ROWE ASSOCIATES INC /MD/ 0 0 0.000%
RENAISSANCE TECHNOLOGIES LLC Jim Simons 0 0 0.000%
BLACKROCK INC. Larry Fink 0 0 0.000%
VANGUARD GROUP INC 0 0 0.000%
CAPTRUST FINANCIAL ADVISORS 0 0 0.000%
GEODE CAPITAL MANAGEMENT, LLC 0 0 0.000%
TOWER RESEARCH CAPITAL LLC (TRC) 0 0 0.000%
US BANCORP \DE\ 0 0 0.000%
UBS GROUP AG 0 0 0.000%